3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Zepp Health's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -21.36%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Zepp Health's 3-Year ROIIC % or its related term are showing as below:
FRA:ST0's 3-Year ROIIC % is ranked worse than 75.63% of 2372
companies
in the Hardware industry
Industry Median: 2.35
vs FRA:ST0: -21.36
Zepp Health (FRA:ST0) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Zepp Health 3-Year ROIIC % Related Terms
Zepp Health 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Zepp Health's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:ST0 vs UEIC, AXIL, KOSS: 3-Year ROIIC % Comparison
For the Consumer Electronics subindustry, Zepp Health's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zepp Health 3-Year ROIIC % vs Hardware Industry
For the Hardware industry and Technology sector, Zepp Health's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Zepp Health's 3-Year ROIIC % falls into.
Zepp Health's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -24.962 (Dec. 2025) - -48.0866355 (Dec. 2022) )
/
( 382.542 (Dec. 2025) - 518.782 (Dec. 2022) )
=
23.1246355
/
-136.24
=
-16.97%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Zepp Health (FRA:ST0) has a 3-Year ROIIC % of -21.36 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Zepp Health and its competitors. According to the industry distribution chart, Zepp Health ranks #1794 out of 2372 companies in the Hardware industry, placing it in the top 75.6%.
Is Zepp Health's 3-Year ROIIC % too high?
Zepp Health's current 3-Year ROIIC % is -21.36. Based on the distribution chart, Zepp Health ranks #1794 out of 2372 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Zepp Health has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zepp Health's 3-Year ROIIC % compare to UEIC and AXIL?
According to the Hardware industry distribution chart, Zepp Health ranks #1794 out of 2372 companies for 3-Year ROIIC %. This places Zepp Health in the lower half of its industry. The industry median 3-Year ROIIC % is 2.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Hardware company?
The median 3-Year ROIIC % among Hardware companies is 2.35, based on 2,372 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Zepp Health and its competitors. For the Hardware industry, the median 3-Year ROIIC % is 2.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zepp Health's current 3-Year ROIIC % is -21.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zepp Health stock overvalued right now?
Based on GuruFocus' analysis, Zepp Health (FRA:ST0) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.27, compared to a current price of €4.50 — trading 37.6% above its estimated fair value. The current 3-Year ROIIC % is -21.36. Zepp Health's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Zepp Health (FRA:ST0), the current 3-Year ROIIC % is -21.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zepp Health (FRA:ST0) Overvalued in 2026?
Based on GuruFocus' analysis, Zepp Health stock appears to be overvalued.
The current stock price of €4.50 is trading 37.6% above its estimated GF Value™ of €3.27.
GuruFocus considers Zepp Health to be Significantly Overvalued.
Key valuation signals for FRA:ST0:
3-Year ROIIC %: -21.36
GF Value™: €3.27 vs. price of €4.50 (37.6% above fair value)
No single metric tells the full story. See the FRA:ST0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
39GF Score
Get the complete analysis for FRA:ST0
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ST0 has been successfully added to your 
